Neuropsychiatric systemic lupus erythematosus (NPSLE) is a generic definition referring to
a series of neurological and psychiatric symptoms directly related to systemic lupus …

Antiphospholipid syndrome was first described 27 years ago in patients with systemic lupus
erythematosus (SLE) and positive anticardiolipin antibodies, who presented with a clotting …

Objectives. Neuropsychiatric (NP) involvement is a poorly understood manifestation of SLE.
We studied post-mortem histopathology in relation to clinical NPSLE syndromes and …

Objective In patients with systemic lupus erythematosus (SLE) and lupus nephritis, the presence
of antiphospholipid antibodies (aPL) is considered to be an indication of increased risk …

Objective. To describe clinical phenotypes in neuropsychiatric systemic lupus erythematosus
(NPSLE). Methods. Data were prospectively collected in the Leiden NPSLE referral clinic, …

Background Different pathogenetic pathways have been proposed for neuropsychiatric (NP)
manifestations in systemic lupus erythematosus (SLE). Objective To describe the patient …

Objectives To determine the 5-year outcomes of early remission induction therapy followed
by targeted treatment aimed at drug-free remission (DFR) in patients with early arthritis. …

Systemic lupus erythematosus is an inflammatory autoimmune disease with multi-organ
involvement. Central nervous system involvement in systemic lupus erythematosus is common …

Background Articular manifestations are common in systemic lupus erythematosus (SLE)
whereas erosive disease is not. Antibodies to cyclic citrullinated peptide (anti-CCP) are …

Objective To determine the contribution of reassessment in the attribution process of
neuropsychiatric (NP) events to SLE or other aetiologies in a large, prospective and …